NCT04903548 2024-11-18Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC with Y90 SIR-SpheresMethodist Health SystemCompleted1 enrolled
NCT06447727 2024-06-07Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLMZhongda HospitalRecruiting30 enrolled